(Q38127283)

29 August 2017

title

13th Asia-Pacific Congress of Clinical Microbiology and Infection Consensus Guidelines for diagnosis and treatment of liver failure (English)

1 reference

29 August 2017

author name string

Organization Committee of 13th Asia-Pacific Congress of Clinical Microbiology and Infection

series ordinal

1

1 reference

29 August 2017

publication date

1 August 2013

1 reference

Hepatobiliary & Pancreatic Diseases International

29 August 2017

published in

1 reference

29 August 2017

volume

12

1 reference

29 August 2017

issue

4

1 reference

29 August 2017

page(s)

346-354

1 reference

AASLD position paper: the management of acute liver failure

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL).

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Introduction to the revised American Association for the Study of Liver Diseases Position Paper on acute liver failure 2011.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Regulatory polymorphisms in the promoter of CXCL10 gene and disease progression in male hepatitis B virus carriers.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Epidemiological and clinical features of hepatitis B virus related liver failure in China

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Hepatitis B: reflections on the current approach to antiviral therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

A revisit of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in non-Hodgkin's lymphoma: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Lamivudine for the treatment of hepatitis B virus reactivation following chemotherapy for non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Intravenous acetylcysteine in paracetamol induced fulminant hepatic failure: a prospective controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose. Analysis of the national multicenter study (1976 to 1985)

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Efficacy of superactivated charcoal administered late (3 hours) after acetaminophen overdose

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Chemotherapy of Amanita phalloides poisoning with intravenous silibinin

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Treatment of amatoxin poisoning: 20-year retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Characterization of fecal microbial communities in patients with liver cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Controlled trial of dexamethasone and mannitol for the cerebral oedema of fulminant hepatic failure

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

A double-blinded, randomized trial of hydrocortisone in acute hepatic failure. The Acute Hepatic Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Factors associated with severe intracranial hypertension in candidates for emergency liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Elevated body temperature independently contributes to increased length of stay in neurologic intensive care unit patients

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Management of acute liver failure

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Acid suppression in peptic ulcer haemorrhage: a 'meta-analysis'

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Initial experience with the modified extracorporeal liver-assist device for patients with fulminant hepatic failure: system modifications and clinical impact

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Immediate intraportal transplantation of human bone marrow mesenchymal stem cells prevents death from fulminant hepatic failure in pigs.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: short-term and long-term outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: a preliminary study

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Indication criteria for liver transplantation for acute liver failure in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Transplantation for acute liver failure: perioperative management

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Hepatitis B prophylaxis post liver transplantation with newer nucleos(t)ide analogues after hepatitis B immunoglobulin discontinuation

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Prevention of post liver transplant HBV recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

Early and extended therapy for recurrent hepatitis C after liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

A randomized controlled trial of pretransplant antiviral therapy to prevent recurrence of hepatitis C after liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1499-3872%2813%2960055-7

7 January 2021

10.1016/S1499-3872(13)60055-7

Identifiers

DOI

1 reference

29 August 2017

1 reference